Ferritin in cancer therapy: A pleiotropic tumoraffin nanocage‐based transport
Guodong Deng,Yang Li,Ning Liang,Pingping Hu,Yan Zhang,Lili Qiao,Yingying Zhang,Jian Xie,Hui Luo,Fei Wang,Fangjie Chen,Fengjun Liu,Deguo Xu,Jiandong Zhang
DOI: https://doi.org/10.1002/cam4.5778
IF: 4.711
2023-04-02
Cancer Medicine
Abstract:Ferritin nanocarriers have a good prospect in the treatment of cancer. Based on the specific targeting of ferritin to tumor cells, ferritin nanocarriers can deliver drugs to mouse tumor tissues by loading therapeutic drugs or modifying them on the surface of ferritin. This allows for precise treatment of tumors with fewer side effects. In conclusion, ferritin nanocarriers can provide a promising therapeutic strategy for the treatment of tumors. Background Ferritin, a ubiquitously distributed iron storage protein, can specifically target tumor cells through transferrin receptor 1. Due to its rearrangeable nanocage structure, ferritin can be loaded with anticancer drugs. Combined with amino acid modifications on the outer‐ and/or inner‐spaces of the nanocage, ferritins can be further coupled with antigens, antibodies, and nucleotide sequences. Since ferritin is naturally presented in the human body, when used in vivo, ferritin exhibits good biocompatibility, and no immunogenic response occurs. These makes ferritin an ideal nanocarrier which shows broad application prospects in cancer therapy. Methods In this study, to find articles, a search was made in PubMed with the keywords ferritin, drug delivery, drug delivery, and cancer treatment. Results According to the investigation, some studies suggest that ferritin can be loaded with drugs and targeted for delivery to tumor tissue. Therefore, ferritin nanocarriers loaded with drugs can be used in chemotherapy, photodynamic therapy (PDT), photothermal therapy (PTT) and immunotherapy. Importantly, the specific targeting of ferritin nanocarriers to tumor cells increases the effectiveness of related therapies and reduces side effects. Conclusions We conclude in this paper that the superior properties of ferritin nanocarriers as an emerging drug delivery system make them a promising cancer treatment strategy. In the future, it is worth conducting clinical trials to further investigate the safety and efficacy of ferritin nanocarriers in patients.
oncology